Treatment and prevention of otitis media

Annals of Pharmacotherapy

Volumn 34, Issue 12, 2000, Pages 1452-1468

  Erramouspe, John ^a   Heyneman, Catherine A ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Antibiotics; Conjugate pneumococcal vaccine; Influenza vaccine; Oligosaccharides; Otitis media; Prophylaxis; Resistance; Streptococcus pneumoniae; Xylitol

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN DERIVATIVE; LORACARBEF; PNEUMOCOCCUS VACCINE; XYLITOL;

ADENOIDECTOMY; ANTIBIOTIC RESISTANCE; DIARRHEA; DOSE RESPONSE; DRUG APPROVAL; DRUG CHOICE; DRUG COST; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; MYRINGOTOMY; OTITIS MEDIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TYMPANOSTOMY TUBE; UPPER RESPIRATORY TRACT INFECTION;

AMOXICILLIN; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; OTITIS MEDIA; PENICILLINS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0033634985     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19391     Document Type: Review

References (129)

1. Management
2. Acute otitis media in the 1990s: The impact of antibiotic resistance
3. Office visits for otitis media: United States, 1975-1990
4. Preventing otitis media: Medical approaches
5. Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric Medicaid population
6. Strategies to control recurrent acute otitis media in infants and children
7. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the drug-resistant Streptococcus pneumoniae therapeutic working group
8. Performance standards for antimicrobial susceptibility testing
9. Performance standards for antimicrobial susceptibility testing
10. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: Support from in vitro pharmacodynamic studies
11. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media
12. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media
13. Controversy in otitis media management: Should we follow the CDC recommendations?
14. Diagnosis and management of otitis media in 1998
15. Implications of drug-resistant Streptococcus pneumoniae for otitis media
16. Clinical efficacy of antimicrobial drugs for acute otitis media: Metaanalysis of 5400 children from thirty-three randomized trials
17. Acute otitis media: A new treatment strategy
18. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis
19. Diagnosis and antibiotic treatment of acute otitis media: Report from International Primary Care Network
20. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media
21. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The 'Pollyanna phenomenon'
22. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
23. Acute otitis media: Clinical course among children who received a short course of high dose antibiotic
24. Management of acute otitis media caused by resistant pneumococci in infants
25. Strategies for dealing with amoxicillin failure in acute otitis media
26. A three step approach to treating otitis media
27. Antimicrobial therapy of acute otitis media: Review of treatment recommendations
28. Pathogens isolated during treatment failures in otitis
29. Microbiologic characteristics of persistent otitis media
30. Clinical implications of antibiotic resistance for management of acute otitis media
31. Safety and tolerability of a new formulation (90mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae
32. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: Clinical efficacy and change in nasopharyngeal flora
33. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children
34. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media
35. A double-blind taste comparison of pediatric antibiotic suspensions
36. Cefprozil treatment of persistent and recurrent acute otitis media
37. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective US study
38. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994-1995: Results of a 30-center national surveillance study
39. A practical approach to drug-resistant Streptococcus pneumoniae
40. Otitis media - Principles of judicious use of antimicrobial agents
41. Treatment of acute otitis media with a shortened course of antibiotics: A meta-analysis
42. Fundamental basis for rational therapeutics in acute otitis media
43. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study
44. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study
45. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study
46. Cefdinir - A new oral cephalosporin
47. Single-dose intramuscular ceftriaxone for acute otitis media in children
48. Single dose ceftriaxone versus 10 days of cefaclor for otitis media
49. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media
50. Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children: A double blind clinical trial
51. Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media
52. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone (IMN-CRO) in the treatment of non-responsive acute otitis media (NR-AOM)
53. Penetration of ceftriaxone into the middle ear fluid of children
54. A pediatrician's view - Do you do tympanocenteses?
55. Otitis media studies should require tympanocentesis - Advisory cmte
56. Antimicrobial prophylaxis for recurrent acute otitis media
57. Language, speech sound production, and cognition in three-year-old children in relation to otitis media in their first three years of life
58. Staving off acute otitis media. When is prophylaxis with antibiotics desirable?
59. Protecting the therapeutic advantage of antimicrobial agents used for otitis media
60. What role for antibiotics in otitis media and sinusitis?
61. Prophylaxis for recurrent acute otitis media: A Brazilian study
62. Sulphamethoxazole prophylaxis in the otitis-prone child
63. Prophylaxis of recurrent acute otitis media and middle-ear effusion: Comparison of amoxicillin with sulfamethoxazole and trimethoprim
64. Sulfisoxazole prophylaxis of middle ear effusion and recurrent acute otitis media
65. Continuous twice daily or once daily amoxicillin prophylaxis compared with placebo for children with recurrent acute otitis media
66. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion
67. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
68. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network
69. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio
70. Resistant pneumococci: Protecting patients through judicious use of antibiotics
71. Antibiotic-resistant Streptococcus pneumoniae in acute otitis media: Overview and update
72. Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis
73. Epidemiology of acute otitis media in children
74. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children
75. Effectiveness of continuous vs. intermittent amoxicillin to prevent episodes of otitis media
76. Prevention of recurrent acute otitis media in otitis-prone children by intermittent prophylaxis with penicillin
77. Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media
78. The use of trimethoprim-sulfamethoxazole in children: A review of adverse reactions and indications
79. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity
80. Serious dermatologic reactions in children
81. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: Effect on the recovery of penicillin-resistant bacteria from children
82. Chemoprophylaxis for recurrent acute otitis media
83. Treatment of acute otitis media in an era of increasing microbial resistance
84. Consensus: Management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin
85. Role of surgery for otitis media in the era of resistant bacteria
86. Therapy of acute otitis media: Myringotomy, antibiotics, or neither? A double-blind study in children
87. Myringotomy in acute otitis media. A controlled study
88. Treatment of acute suppurative otitis media
89. Evaluation of ventilating tubes and myringotomy in the treatment of recurrent or persistent otitis media
90. Prevention of recurrent acute otitis media: Chemoprophylaxis versus tympanostomy tubes
91. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: Results of a randomized clinical trial
92. Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia
93. Effect of xylitol on growth of nasopharyngeal bacteria in vitro
94. Antiadhesive effects of xylitol on otopathogenic bacteria
95. Xylitol chewing gum in prevention of acute otitis media: Double blind randomised trial
96. A novel use of xylitol sugar in preventing acute otitis media
97. Pneumococcal conjugate vaccines
98. Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama
99. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children - Implications for vaccine strategies
100. Prevention of otitis media in children by pneumococcal vaccination
101. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of a conjugate vaccine
102. ACIP Prevnar coverage recommendation includes prioritization plan
103. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory
104. Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid
105. 197 in United States infants
106. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
107. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
108. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis (RE9960)
109. Humoral immune response in acute otitis media
110. 2 antibody response in children with recurrent otitis media acuta
111. Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection
112. Oral immunization with a Streptococcus pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides
113. Prevalence of various respiratory viruses in the middle ear during acute otitis media
114. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction
115. Influenza vaccination in the prevention of acute otitis media in children
116. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care
117. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children
118. Viruses in acute otitis media: Increasing evidence for clinical significance
119. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma
120. Potential cost savings attributable to influenza vaccination of school-aged children
121. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media
122. A meta-analytic review of the risk factors for acute otitis media
123. Maternal cigarette smoking during pregnancy is an independent predictor for symptoms of middle ear disease at five years' postdelivery
124. Pacifier use and otitis media in infants twelve months of age or younger
125. Otitis media in 2253 Pittsburgh-area infants: Prevalence and risk factors during the first two years of life